SEC Form 4 · accession 0001209191-15-079331
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Silverman
Officer — Senior VP, General Counsel
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2015 | M | 3,600 | $1.13 | A | 13,600 | D | |
| Common StockF1 | Nov 9, 2015 | F | 185 | $21.95 | D | 13,415 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.13 | Nov 9, 2015 | M | 3,600 | D | — | Jun 4, 2017 | Common Stock | 3,600 | 19,497 | D |
Explanation of responses
- F1This Form is being filed to report the exercise of a stock option for a total of 3,600 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder attests to the ownership of enough shares of stock already owned by the option holder to cover the exercise price of the option being exercised. As a result of this stock swap, the Reporting Person acquired ownership of an additional 3,415 shares of common stock.
- F2Immediately.